ESSA Pharma Statistics Share Statistics ESSA Pharma has 44.34M
shares outstanding. The number of shares has increased by 0.04%
in one year.
Shares Outstanding 44.34M Shares Change (YoY) 0.04% Shares Change (QoQ) 0% Owned by Institutions (%) 71.37% Shares Floating 41.67M Failed to Deliver (FTD) Shares 1,142 FTD / Avg. Volume 0.48%
Short Selling Information The latest short interest is 685.65K, so 1.55% of the outstanding
shares have been sold short.
Short Interest 685.65K Short % of Shares Out 1.55% Short % of Float 1.98% Short Ratio (days to cover) 1.49
Valuation Ratios The PE ratio is -9.4 and the forward
PE ratio is -3.89.
ESSA Pharma's PEG ratio is
-1.41.
PE Ratio -9.4 Forward PE -3.89 PS Ratio 0 Forward PS 3.8 PB Ratio 2.09 P/FCF Ratio -11.81 PEG Ratio -1.41
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for ESSA Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 38.64,
with a Debt / Equity ratio of 0.
Current Ratio 38.64 Quick Ratio 38.64 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-815.51K Employee Count 35 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -57.74% in the
last 52 weeks. The beta is 1.56, so ESSA Pharma's
price volatility has been higher than the market average.
Beta 1.56 52-Week Price Change -57.74% 50-Day Moving Average 1.78 200-Day Moving Average 1.89 Relative Strength Index (RSI) 67.48 Average Volume (20 Days) 239,504
Income Statement
Revenue n/a Gross Profit n/a Operating Income -34.42M Net Income -28.54M EBITDA -28.45M EBIT n/a Earnings Per Share (EPS) -0.64
Full Income Statement Balance Sheet The company has 103.71M in cash and 329.26K in
debt, giving a net cash position of 103.38M.
Cash & Cash Equivalents 103.71M Total Debt 329.26K Net Cash 103.38M Retained Earnings n/a Total Assets 115.42M Working Capital 113.45M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -22.72M
and capital expenditures 0, giving a free cash flow of -22.72M.
Operating Cash Flow -22.72M Capital Expenditures n/a Free Cash Flow -22.72M FCF Per Share -0.51
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields EPIX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for EPIX is $2,
which is 4.7% higher than the current price. The consensus rating is "Hold".
Price Target $2 Price Target Difference 4.7% Analyst Consensus Hold Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 25, 2018. It was a
backward
split with a ratio of 1:20.
Last Split Date Apr 25, 2018 Split Type backward Split Ratio 1:20
Scores Altman Z-Score 24.67 Piotroski F-Score 2
